Niagen Bioscience Inc (NAGE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Niagen Bioscience Inc

    NASDAQ: NAGE · Real-Time Price · USD
    9.61
    -0.01 (-0.10%)
    At close: Sep 12, 2025, 3:59 PM
    9.79
    1.87%
    After-hours: Sep 12, 2025, 05:35 PM EDT

    Niagen Bioscience Inc Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 8.55M -4.94M -16.54M -27.13M
    Depreciation & Amortization
    		 1.48M 1.71M 1.88M 1.63M
    Stock-Based Compensation
    		 3.66M 4.75M 5.74M 6.2M
    Other Working Capital
    		 147K 1.66M -875K -1.21M
    Other Non-Cash Items
    		 -4.71M 977K -167K -124K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 3.13M 4.62M -6.01M -4.73M
    Operating Cash Flow
    		 12.11M 7.12M -15.1M -24.16M
    Capital Expenditures
    		 -163K -148K -334K -409K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 20K 5K n/a n/a
    Investing Cash Flow
    		 -143K -143K -334K -409K
    Debt Repayment
    		 -11K -15K -16K -31K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -52K -75K -77K 9.38M
    Financial Cash Flow
    		 5.37M -90K 7.65M 36.09M
    Net Cash Flow
    		 17.34M 6.88M -7.78M 11.52M
    Free Cash Flow
    		 11.95M 6.97M -15.43M -24.57M

    Add to Watchlist